Abstract
Autoimmune hemolytic anemia (AIHA) is an acquired disorder characterized by the production of autoantibodies with high affinity for autologous erythrocyte antigens causing red blood cell (RBC) destruction and a resultant wide spectrum of symptomatology and laboratory findings. The severity of presentation highly depends on the autoantibody type, concentration, affinity, antigen type, expression level, and antibody-antigen thermodynamics. Although AIHA is a relatively rare disorder with an estimated incidence of 1–3 cases per 100,000 per year, basic understanding of its manifestations and standard diagnostics is essential for healthcare providers in various clinical settings, as severe forms of the disease can be life-threatening. Early recognition and initiation of appropriate treatment are critical to achieving a positive outcome. Additionally, autoimmune hemolysis is frequently the presenting manifestation of a myriad of underlying autoimmune, infectious and/or neoplastic processes, and awareness of such association allows for earlier diagnosis and management of these disorders. On the other hand, even isolated subclinical immune hemolysis can sometimes complicate the interpretability of common laboratory tests and standard blood banking procedures.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Morgagni G, Alexander B. The seats and causes of diseases investigated by anatomy; in five books, containing a great variety of dissections, with remarks. To which are added very accurate and copious indexes of the principal things and names therein contained. London: Printed for A. Millar, and T. Cadell; 1769.
Freedman J. Autoimmune hemolysis: a journey through time. Transfus Med Hemother. 2015;42(5):278–85.
Andral G. Essai d'hématologie pathologique. Paris: Fortin, Masson et Cie; 1843.
Major RH. Classic descriptions of disease. Springfield, IL: C. C. Thomas; 1939.
Vanlair C, Masius J. De la microcythémia. Bull Acad R Med Belg. 1871;5:515–612.
Mackenzie S. Paroxysmal haemoglobinuria, with remarks on its nature. Lancet. 1879;II:116–7.
Minkowski O. Ueber eine hereditäre, unter dem Bilde eines chronischen Icterus mit Urobilinurie, Splenomegalie und Nierensiderosis verlaufende Affection. Verh Krong Inn Med. 1900;1(18):316–21.
Hayem G. Sur une variete particuliere d’ictere chronique. Ictere infectieux chronique splenomegalique. Presse Méd. 1898;1(6):121–5.
Landsteiner K. Zur Kentniss der antifermentativen, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zbl Bakt. 1900;1(27):357–62.
Donath JLK. Über paroxysmale Hämoglobinurie. Münch Med Wochenschr. 1904;1(51):1590–5.
Chauffard M. Pathogénie de l’ictère congenital de l’adulte. Semaine Med. 1907;1(27):25–9.
Chauffard M, Troissier J. Anémie grave avec hémolysinique dans le sérum; ictère hémolysiniqe. Semaine Med. 1908;1(28):345.
Chauffard M, Vincent C. Hémoglobinurie hémolysinique avec ictère polycholique aigu. Semaine Med. 1909;1(29):601–4.
Micheli F. Unmittelbare Effekte der Splenektomie bei einem Fall von erworbenem hämolytischen splenomegalischen Ikterus Typus Hayem-Widal (spleno-hämolytischer Ikterus). Wien Klin Wochenschr. 1911;1(24):1269–74.
Banti G. La esplanomegalia hemolitica. Semaine Med. 1912;1(32):265–8.
Witts LJ. The paroxysmal haemoglobinurias. Lancet. 1936;II:115–20.
Dameshek W, Schwartz SO. The presence of hemolysins in acute hemolytic anemia. New Engl J Med. 1938;218:75–80.
Weiner AS. A new test (blocking test) for Rh sensitization. Proc Soc Exp Biol NY. 1944;56(2):173–6.
Race RR. An ‘incomplete’ antibody in human serum. Nature. 1944;153(3895):771–2.
Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol. 1945;26:255–66.
Evans RS, Duane RT. Acquired hemolytic anemia; the relation of erythrocyte antibody production to activity of the disease; the significance of thrombocytopenia and leukopenia. Blood. 1949;4(11):1196–213.
Iafusco F, Buffa V. Autoimmune hemolytic anemia in a newborn infant. Pediatria. 1962;70:1256–64.
Pirofsky B. The hemolytic anemias—historical review and classification. The hemolytic anemias—historical review and classification. 1. Baltimore, MA: Williams & Wilkins; 1969. p. 3–21.
Schubothe H. Current problems of chronic cold hemagglutinin disease. Annals NY Acad Sci. 1965;124(2):484–90.
Dacie JV. Aetiology of the auto-immune haemolytic anaemias. Haematologia. 1971;5(4):351–7.
Rosse WF. The autinglobulin test in autoimmune hemolytic anemia. Annu Rev Med. 1975;26:331–6.
Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest. 1972;51(3):575–82.
Engelfriet CP, Borne AE, Beckers D, Van Loghem JJ. Autoimmune haemolytic anaemia: serological and immunochemical characteristics of the autoantibodies; mechanisms of cell destruction. Ser Haematol. 1974;7(3):328–47.
von dem Borne AE, Beckers D, Engelfriet CP. Mechanisms of red cell destruction mediated by non-complement binding IgG antibodies: the essential role in vivo of the Fc part of IgG. Br J Haematol. 1977;36(4):485–93.
Berentsen S, Randen U, Tjonnfjord GE. Cold agglutinin-mediated autoimmune hemolytic anemia. Hematol Oncol Clin North Am. 2015;29(3):455–71.
Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol. 1992;29(1):3–12.
Naik R. Warm autoimmune hemolytic anemia. Hematol Oncol Clin North Am. 2015;29(3):445–53.
Quist E, Koepsell S. Autoimmune hemolytic anemia and red blood cell autoantibodies. Arch Pathol Lab Med. 2015 Nov;139(11):1455–8.
Segel GB, Lichtman MA. Direct antiglobulin (“Coombs”) test-negative autoimmune hemolytic anemia: a review. Blood Cells Mol Dis. 2014;52(4):152–60.
Shanbhag S, Spivak J. Paroxysmal cold hemoglobinuria. Hematol Oncol Clin North Am. 2015;29(3):473–8.
Shulman IA, Branch DR, Nelson JM, Thompson JC, Saxena S, Petz LD. Autoimmune hemolytic anemia with both cold and warm autoantibodies. Jama. 1985;253(12):1746–8.
Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Direct antiglobulin titer strength and hyperbilirubinemia. Pediatrics. 2014;134(5):e1340–4.
Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS. The direct antiglobulin test: a critical step in the evaluation of hemolysis. Am J Hematol. 2012;87(7):707–9.
Habibi B, Homberg JC, Schaison G, Salmon C. Autoimmune hemolytic anemia in children. A review of 80 cases. Am J Med. 1974;56(1):61–9.
Barker RN, Hall AM, Standen GR, Jones J, Elson CJ. Identification of T-cell epitopes on the rhesus polypeptides in autoimmune hemolytic anemia. Blood. 1997;90(7):2701–15.
Liebman HA, Weitz IC. Autoimmune hemolytic anemia. Med Clin North Am. 2017;101(2):351–9.
Petz LD, Fudenberg HH. Coombs-positive hemolytic anemia caused by penicillin administration. N Engl J Med. 1966;274(4):171–8.
Garratty G. Drug-induced immune hemolytic anemia. Hematology/the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2009;73–9.
Ahmad E, Elgohary T, Ibrahim H. Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia. J Investig Allergol Clin Immunol. 2011;21(4):297–304.
Visco C, Barcellini W, Maura F, Neri A, Cortelezzi A, Rodeghiero F. Autoimmune cytopenias in chronic lymphocytic leukemia. Am J Hematol. 2014;89(11):1055–62.
De Angelis V, Biasinutto C, Pradella P, Vaccher E, Spina M, Tirelli U. Clinical significance of positive direct antiglobulin test in patients with HIV infection. Infection. 1994;22(2):92–5.
Rosse WF. Fixation of the first component of complement (C’la) by human antibodies. J Clin Invest. 1969;47(11):2430–45.
Ravetch JV. Fc receptors. Curr Opin Immunol. 1997;9(1):121–5.
Schur PH. IgG subclasses—a review. Ann Allergy. 1987;58(2):89–96.
Garratty G, Arndt P, Domen R, Clarke A, Sutphen-Shaw D, Clear J, et al. Severe autoimmune hemolytic anemia associated with IgM warm autoantibodies directed against determinants on or associated with glycophorin A. Vox Sang. 1997;72(2):124–30.
Sachs UJ, Roder L, Santoso S, Bein G. Does a negative direct antiglobulin test exclude warm autoimmune haemolytic anaemia? A prospective study of 504 cases. Br J Haematol. 2006;132(5):655–6.
Lau P, Haesler WE, Wurzel HA. Positive direct antiglobulin reaction in a patient population. Am J Clin Pathol. 1976;65(3):368–75.
Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993;7(4):199–207.
Jeffries M, Hamadeh F, Aberle T, Glenn S, Kamen DL, Kelly JA, et al. Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective. Lupus. 2008;17(8):739–43.
Iordache L, Launay O, Bouchaud O, Jeantils V, Goujard C, Boue F, et al. Autoimmune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev. 2014;13(8):850–7.
Toy PT, Reid ME, Burns M. Positive direct antiglobulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome (AIDS). Am J Hematol. 1985;19(2):145–50.
Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25(1):57–62.
Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118(18):4798–807.
Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol. 1986;39(7):713–6.
Diehl LF, Ketchum LH. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol. 1998;25(1):80–97.
Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology. 2007;23(3):105–19.
LoBuglio AF, Jandl JH. The nature of the alpha-methyldopa red-cell antibody. N Engl J Med. 1967;276(12):658–65.
Worlledge SM, Carstairs KC, Dacie JV. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet. 1966;2(7455):135–9.
Salama A, Santoso S, Mueller-Eckhardt C. Antigenic determinants responsible for the reactions of drug-dependent antibodies with blood cells. Br J Haematol. 1991;78(4):535–9.
Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood. 1987;69(4):1006–10.
Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 1987;69(3):820–6.
Dobryszycka W. Biological functions of haptoglobin—new pieces to an old puzzle. Eur J Clin Chem Clin Biochem. 1997;35(9):647–54.
Shih AW, McFarlane A, Verhovsek M. Haptoglobin testing in hemolysis: measurement and interpretation. Am J Hematol. 2014;89(4):443–7.
Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980;243(19):1909–11.
Pollack W, Hager HJ, Reckel R, Toren DA, Singher H. A study of the forces involved in the second stage of Hemagglutination. Transfusion. 1965;5:158–83.
Kirschfink M, Knoblauch K, Roelcke D. Activation of complement by cold agglutinins. Infusionsther Transfusionsmed. 1994;21(6):405–9.
Jenkins WJ, Marsh WL, Noades J, Tippett P, Sanger R, Race RR. The I antigen and antibody. Vox Sang. 1960;5:97–121.
Marsh WL. Anti-i: a cold antibody defining the Ii relationship in human red cells. Br J Haematol. 1961;7:200–9.
Feizi T. Monotypic cold agglutinins in infection by mycoplasma pneumoniae. Nature. 1967;215(5100):540–2.
Deaton JG, Skaggs H Jr, Levin WC. Acute hemolytic anemia complicating infectious mononucleosis: the mechanism of hemolysis. Tex Rep Biol Med. 1967;25(3):309–17.
Rollof J, Eklund PO. Infectious mononucleosis complicated by severe immune hemolysis. Eur J Haematol. 1989;43(1):81–2.
Swiecicki PL, Hegerova LT, Gertz MA. Cold agglutinin disease. Blood. 2013;122(7):1114–21.
Sokol RJ, Hewitt S, Stamps BK, Hitchen PA. Autoimmune haemolysis in childhood and adolescence. Acta Haematol. 1984;72(4):245–57.
Gottsche B, Salama A, Mueller-Eckhardt C. Donath-Landsteiner autoimmune hemolytic anemia in children. A study of 22 cases. Vox Sang. 1990;58(4):281–6.
Heddle NM. Acute paroxysmal cold hemoglobinuria. Transfus Med Rev. 1989;3(3):219–29.
Qiao L, Chen J, Leng XM, Zhang W, Han B, Zhao Y, et al. Agranulocytosis and mixed-type autoimmune hemolytic anemia in primary sjogren’s syndrome: a case report and review of the literature. Int J Rheum Dis. 2016;19(12):1351–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Qasim, S. (2018). Background, Presentation and Pathophysiology of Autoimmune Hemolytic Anemia. In: Despotovic, J. (eds) Immune Hematology. Springer, Cham. https://doi.org/10.1007/978-3-319-73269-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-73269-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73268-8
Online ISBN: 978-3-319-73269-5
eBook Packages: MedicineMedicine (R0)